Larvol Delta - Quantum-Leap-Healthcare-Collaborative-Initiates-Landmark-Phase-2-RECAST-DCIS-Platform-Trial-to-Evaluate-Alternative-DCIS-Treatments-with-Atossa-Therapeutics-Havah-Therapeutics-and-the-Menarini-Group

Orserdu (elacestrant) - Menarini

Z-endoxifen - Atossa Therap

https://www.prnewswire.com/news-releases/quantum-leap-healthcare-collaborative-initiates-landmark-phase-2-recast-dcis-platform-trial-to-evaluate-alternative-dcis-treatments-with-atossa-therapeutics-havah-therapeutics-and-the-menarini-group-301971653.html

Oct 30, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next